However, the antitumor effects of siRNA in a mouse xenograft tumor model demonstrated that ITGA11 siRNA treatment outperformed EZH2 siRNA treatment, indicating the superior efficacy of ITGA11 siRNA in suppressing tumor growth. This evidence concerns the gene EZH2 and neoplasm.